S. 2255Senate109th Congress (2005-2007)In Committee

Medicare Drug Formulary Protection Act

Introduced February 8, 2006

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions
SenateIntro Referral Latest Action

Read twice and referred to the Committee on Finance.

February 8, 2006

View full timeline
SenateIntro Referral

Introduced in Senate

February 8, 2006

SenateIntro Referral

Sponsor introductory remarks on measure. (CR S865-866)

February 8, 2006

SenateIntro Referral

Read twice and referred to the Committee on Finance.

February 8, 2006

Floor Debate

4 members

What members said about S. 2255 on the floor

1 Republican3 Democrats
Conrad R. Burns
Sen. Conrad R. BurnsR-MT · Feb 8, 2006

Mr. President, this is a special day to those of us who serve on the Commerce Committee and have served on the Commerce Committee ever since we have been in the Senate because today is the 10th…

Barack Obama
Sen. Barack ObamaD-IL · Feb 8, 2006

Mr. President, I rise today to introduce the Hurricane Katrina Working Family Tax Relief Act of 2006. I am proud to introduce this bill, along with Senators Landrieu, Durbin, and Kerry, to keep a…

Dianne Feinstein
Sen. Dianne FeinsteinD-CA · Feb 8, 2006

Mr. President, today I am introducing legislation along with Senators Collins, Dorgan, Snowe, Bingaman, Chafee, Clinton, Schumer, Murray and Boxer to ensure that when a senior signs up for a Medicare…

Dianne Feinstein
Sen. Dianne FeinsteinD-CA · Feb 8, 2006

Mr. President, today I am introducing legislation along with Senators Collins, Dorgan, Snowe, Bingaman, Chafee, Clinton, Schumer, Murray and Boxer to ensure that when a senior signs up for a Medicare…

Byron L. Dorgan
Sen. Byron L. DorganD-ND · Feb 8, 2006

Mr. President, I am pleased to join Senators Feinstein, Collins and a number of my other colleagues to introduce the Medicare Drug Formulary Protection Act of 2006. This legislation will improve the…

Show 1 more
Byron L. Dorgan
Sen. Byron L. DorganD-ND · Feb 8, 2006

Mr. President, I am pleased to join Senators Feinstein, Collins and a number of my other colleagues to introduce the Medicare Drug Formulary Protection Act of 2006. This legislation will improve the…

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in SenateIssued February 8, 2006

II

109th CONGRESS

2d Session

S. 2255

IN THE SENATE OF THE UNITED STATES

February 8, 2006

Mrs. Feinstein (for herself, Ms. Collins, Mr. Dorgan, Ms. Snowe, Mr. Bingaman, Mr. Chafee, Mrs. Clinton, Mr. Schumer, Mrs. Murray, and Mrs. Boxer) introduced the following bill; which was read twice and referred to the Committee on Finance

A BILL

To amend title XVIII of the Social Security Act to prohibit removal of covered part D drugs from a prescription drug plan formulary during the plan year once an individual has enrolled in the plan.

1.

Short title

This Act may be cited as the Medicare Drug Formulary Protection Act.

2.

Removal of covered part D drugs from the prescription drug plan formulary

(a)

Limitation on removal or change of covered part D drugs from the prescription drug plan formulary

Section 1860D–4(b)(3)(E) of the Social Security Act (42 U.S.C. 1395w–104(b)(3)(E)) is amended to read as follows:

(E)

Removing a drug from formulary or imposing a restriction or limitation on coverage

(i)

Limitation on removal, limitation, or restriction

(I)

In general

Subject to subclause (II) and clause (ii), beginning with 2006, the PDP sponsor of a prescription drug plan may not remove a covered part D drug from the plan formulary or impose a restriction or limitation on the coverage of such a drug (such as through the application of a preferred status, usage restriction, step therapy, prior authorization, or quantity limitation) other than at the beginning of each plan year except as the Secretary may permit to take into account new therapeutic uses and newly covered part D drugs.

(II)

Special rule for newly enrolled individuals

Subject to clause (ii), in the case of an individual who enrolls in a prescription drug plan on or after the date of enactment of this subparagraph, the PDP sponsor of such plan may not remove a covered part D drug from the plan formulary or impose a restriction or limitation on the coverage of such a drug (such as through the application of a preferred status, usage restriction, step therapy, prior authorization, or quantity limitation) during the period beginning on the date of such enrollment and ending on December 31 of the immediately succeeding plan year except as the Secretary may permit to take into account new therapeutic uses and newly covered part D drugs.

(ii)

Exceptions to limitation on removal

Clause (i) shall not apply with respect to a covered part D drug that—

(I)

is a brand name drug for which there is a generic drug approved under section 505(j) of the Food and Drug Cosmetic Act (21 U.S.C. 355(j)) that is placed on the market during the period in which there are limitations on removal or change in the formulary under subclause (I) or (II) of clause (i);

(II)

is a brand name drug that goes off-patent during such period;

(III)

is a drug for which the Commissioner of Food and Drugs issues a clinical warning that imposes a restriction or limitation on the drug during such period; or

(IV)

has been determined to be ineffective during such period.

(iii)

Notice of removal under application of exception to limitation

The PDP sponsor of a prescription drug plan shall provide appropriate notice (such as under subsection (a)(3)) of any removal or change under clause (ii) to the Secretary, affected enrollees, physicians, pharmacies, and pharmacists.

.

(b)

Notice for change in formulary and other restrictions or limitations on coverage

(1)

In general

Section 1860D–4(a) of such Act (42 U.S.C. 1395w–104(a)) is amended by adding at the end the following new paragraph:

(5)

Annual notice of changes in formulary and other restrictions or limitations on coverage

Each PDP sponsor offering a prescription drug plan shall furnish to each enrollee at the time of each annual coordinated election period (referred to in section 1860D–1(b)(1)(B)(iii)) for a plan year a notice of any changes in the formulary or other restrictions or limitations on coverage of a covered part D drug under the plan that will take effect for the plan year.

.

(2)

Effective date

The amendment made by paragraph (1) shall apply to annual coordinated election periods beginning after the date of the enactment of this Act.